MiNK Therapeutics (INKT) Times Interest Earned (2020 - 2026)
MiNK Therapeutics (INKT) posted Times Interest Earned of $720.45 for Q1 2026, up 2993.5% sequentially from $23.29 in Q4 2025, and up 673.62% YoY from $93.13 in Q1 2025.
MiNK Therapeutics (INKT) Times Interest Earned (2020 - 2026) Analysis & Trends
MiNK Therapeutics has reported Times Interest Earned for 7 years, with the latest figure at $720.45 in Q1 2026.
- Quarterly Times Interest Earned rose 673.62% year-over-year to $720.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175.59 (down 78.73% YoY) and the FY2025 annual result came in at -$0.4, up 95.06% from the prior year.
- Times Interest Earned improved to $720.45 in Q1 2026 per INKT's latest filing, from $23.29 in the prior quarter.
- Over five years, Times Interest Earned peaked at $720.45 in Q1 2026 and troughed at -$953.49 in Q4 2022.
- A 5-year average of $19.3 and a median of -$1.42 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned tumbled 11966.45% in 2022, then jumped 26581.69% in 2024.
- Over 5 years, Times Interest Earned stood at -$953.49 in 2022, then surged by 111.67% to $111.25 in 2023, then slumped by 129.54% to -$32.86 in 2024, then soared by 170.87% to $23.29 in 2025, then jumped by 2993.5% to $720.45 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $720.45, $23.29, and -$0.51 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | MiNK Therapeutics | 60.53 Mn | 60.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.74 |
| Mar 31, 2026 | 720.45 |
| Dec 31, 2025 | 23.29 |
| Sep 30, 2025 | -0.51 |
| Jun 30, 2025 | -2.93 |
| Mar 31, 2025 | 93.13 |
| Dec 31, 2024 | -32.86 |
| Sep 30, 2024 | -1.25 |
| Jun 30, 2024 | -1.46 |
| Mar 31, 2024 | 383.00 |
| Dec 31, 2023 | 111.25 |
| Sep 30, 2023 | -2.27 |
| Jun 30, 2023 | -1.42 |
| Mar 31, 2023 | -1.45 |
| Dec 31, 2022 | -953.49 |
| Sep 30, 2022 | -1.71 |
| Jun 30, 2022 | -2.36 |
| Mar 31, 2022 | -1.28 |
| Dec 31, 2021 | -7.90 |
| Sep 30, 2021 | -1.66 |